Stata DX

About:

Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for clinical studies.

Website: https://www.statadx.com

Top Investors: MassVentures

Description:

Stata DX is a developer of a disease management eRapid technology designed to implement custom biomarker panels for at-home patient monitoring in clinical studies. The company's technology is a low-cost, affinity-based electrochemical sensing platform that can simultaneously detect a wide range of biomarkers in complex biological fluids, specifically liquid MRI for the brain, with high sensitivity and selectivity using as little as a single drop of blood, allowing researchers to learn about the composition of a system in real-time. Stata DX was established in Cambridge, Massachusetts.